B
BioXcel Therapeutics, Inc. (BTAI)
NCM – Real vaqt narxi. Valyuta: USD
1.31
+0.06 (4.80%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.30
-0.01 (-0.76%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.31
+0.06 (4.80%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.30
-0.01 (-0.76%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $100.3M naqd pul zahiralaridan ($17.2M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy majburiyatlar $55.0M jami joriy aktivlardan $33.9M oshib ketdi, likvidlik muammolarini ko'rsatadi
Qarz/kapital nisbati (-1.0) tarmoq o'rtachasidan (-0.8) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-2.4x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$11.8M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 0.62 | 2.52 | 4.0 | |
| Tezkor likvidlik nisbati | 0.61 | 1.78 | 4.0 | |
| Qarz/Kapital nisbati | N/A | -0.80 | 1.0 | |
| Qarz/Aktivlar nisbati | 2.95 | 0.73 | 1.0 | |
| Foiz to‘lov qoplami | -2.41 | -13.90 | 1.0 | |
| O‘rtacha ball | 2.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 375K | 1M | 2M | 642K | 680K |
| Yalpi foyda | 28K | -198K | -186K | 178K | -35K |
| Operatsion daromad | -158M | -166M | -63M | -50M | -50M |
| Sof foyda | -166M | -179M | -60M | -70M | -75M |
| EBITDA | -158M | -166M | -63M | -49M | -50M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 236.1 | 82.76 | 10 |
| Keyingi chorak | 304.95 | 78.21 | 10 |
| Joriy yil | 157.94 | 70.9 | 10 |
| Keyingi yil | 1043.34 | 8.05 | 8.0 |
| O‘rtacha ball | 9.5 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -19.52 | -1.15 | 6.9 | 16.9 | 4.0 |
| Yil/Yil | 22.62 | -74.94 | 64 | 1.94 | 6.0 |
| 3 yil o‘rtacha | 86.85 | 13.81 | 49.29 | 19.71 | 9.3 |
| 5 yil o‘rtacha | 451.71 | -8.73 | 18.97 | -5.74 | 5.3 |
| O‘rtacha ball | 6.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |